Jefferies Financial Group Cuts Foghorn Therapeutics (NASDAQ:FHTX) Price Target to $14.00
Foghorn Therapeutics (NASDAQ:FHTX – Free Report) had its price objective decreased by Jefferies Financial Group from $18.00 to $14.00 in a report released on Monday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. FHTX has been the topic of a number of other reports. Evercore ISI began coverage on Foghorn Therapeutics […]
More Stories
Natuzzi (NYSE:NTZ) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Natuzzi (NYSE:NTZ – Free Report) in a research note released on Monday morning. The...
Art’s-Way Manufacturing (NASDAQ:ARTW) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Art’s-Way Manufacturing (NASDAQ:ARTW – Free Report) in a research note published on Monday. The...
Embraer (NYSE:ERJ) Downgraded to Hold Rating by StockNews.com
StockNews.com downgraded shares of Embraer (NYSE:ERJ – Free Report) from a buy rating to a hold rating in a report...
Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note published on Monday. The...
StockNews.com Initiates Coverage on Hess (NYSE:HES)
StockNews.com began coverage on shares of Hess (NYSE:HES – Free Report) in a report issued on Monday morning. The firm...
Atlantic American (NASDAQ:AAME) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Atlantic American (NASDAQ:AAME – Free Report) in a research report released on Monday morning....